Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination
/in Glioblastoma, International PublicationsDendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme
/in Glioblastoma, International PublicationsPhase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
/in Glioblastoma, International Publications, Newcastle Disease Virus[Current status of hyperthermia for therapy of brain tumor]
/in Glioblastoma, International PublicationsDendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
/in Dendritic Cells, Glioblastoma, International PublicationsActive immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines
/in Glioblastoma, International PublicationsClinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International PublicationsTumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer